Oppenheimer & CO Inc Trans Medics Group, Inc. Transaction History
Oppenheimer & CO Inc
- $7.23 Billion
- Q2 2025
A detailed history of Oppenheimer & CO Inc transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Oppenheimer & CO Inc holds 117,370 shares of TMDX stock, worth $14.8 Million. This represents 0.22% of its overall portfolio holdings.
Number of Shares
117,370
Previous 78,002
50.47%
Holding current value
$14.8 Million
Previous $5.25 Million
199.75%
% of portfolio
0.22%
Previous 0.08%
Shares
13 transactions
Others Institutions Holding TMDX
# of Institutions
358Shares Held
32.1MCall Options Held
852KPut Options Held
690K-
Vanguard Group Inc Valley Forge, PA3.57MShares$450 Million0.0% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL3.11MShares$391 Million0.06% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$333 Million0.01% of portfolio
-
State Street Corp Boston, MA1.31MShares$164 Million0.0% of portfolio
-
Fil LTD Hamilton, D01.23MShares$154 Million0.09% of portfolio
About TransMedics Group, Inc.
- Ticker TMDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 31,831,400
- Market Cap $4B
- Description
- TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...